BMGF – Gates Foundation  [to 19 Jan 2019]
No new digest content identified.
Bill & Melinda Gates Medical Research Institute    [to 19 Jan 2019]
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.
CARB-X   [to 19 Jan 2019]
CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria.
No new digest content identified.
CEPI – Coalition for Epidemic Preparedness Innovations  [to 19 Jan 2019]
17 Jan 2019
CEPI partners with University of Queensland to create rapid-response vaccines
The Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Queensland (UQ)—one of the country’s leading research institutions—have announced a partnering agreement, worth up to US$ 10.6 million (AU$ 14.7 million), to develop a “molecular clamp” vaccine platform, a transformative technology that enables targeted and rapid vaccine production against multiple viral pathogens.
16 Jan 2019
CEPI backs expansion of FIND’s Lassa fever response programme
EDCTP    [to 19 Jan 2019]
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
Latest news
No new digest content identified.
Emory Vaccine Center    [to 19 Jan 2019]
No new digest content identified.
European Medicines Agency  [to 19 Jan 2019]
News and press releases
News: Revised guideline aims to strengthen global approach to development of new antibacterial medicines
European Vaccine Initiative  [to 19 Jan 2019]
15 January 2019
First clinical results of PlacMalVac project published
EVI-supported project publishes first clinical results for vaccine candidate to prevent pregnancy-associated malaria.
FDA [to 19 Jan 2019]
January 15, 2019 –
Statement from FDA Commissioner Scott Gottlieb, M.D. and Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies
The FDA is witnessing a surge of cell and gene therapy products entering early development, evidenced by a large upswing in the number of investigational new drug (IND) applications. Based on this activity, we anticipate that the number of product approvals for cell and gene therapies will grow in the coming years, reflecting significant scientific advancement and the clinical promise of these new innovations…
Fondation Merieux  [to 19 Jan 2019]
No new digest content identified.
Gavi [to 19 Jan 2019]
15 January 2019
Iceland pledges US$1 million to immunise children in Malawi
GHIT Fund   [to 19 Jan 2019]
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that devastate the world’s poorest people. Other funders include six Japanese pharmaceutical
No new digest content identified.
Global Fund  [to 19 Jan 2019]
No new digest content identified.
Hilleman Laboratories   [to 19 Jan 2019]
Date: 18/01/2019
Hilleman Laboratories announces creation of new Strategic Advisory Committee
Human Vaccines Project   [to 19 Jan 2019]
No new digest content identified.
IAVI  [to 19 Jan 2019]
No new digest content identified.
No new digest content identified.
IVAC  [to 19 Jan 2019]
No new digest content identified.
IVI   [to 19 Jan 2019]
IVI News & Announcements
No new digest content identified.
JEE Alliance  [to 19 Jan 2019]
The Alliance adopts a workplan with a focus on thematic dialogues and information sharing
Meeting, Multisectorality, OneHealth
MSF/Médecins Sans Frontières  [to 19 Jan 2019]
Selected News; Project Updates, Reports
DRC 2018 Ebola outbreaks
Ebola patient care increases amid growing tensions in North Kivu
18 Jan 2019

Neglected diseases
Lassa fever: A challenging disease to diagnose and treat
18 Jan 2019

Antibiotic resistance
“Without urgent action, common infections and minor injuries could be deadly again”
17 Jan 2019

Thousands fleeing Rann attack seek refuge in Cameroon
16 Jan 2019

Crisis update: Borno and Yobe states, January 2019
14 Jan 2019

NIH  [to 19 Jan 2019]
No new digest content identified.

PATH  [to 19 Jan 2019]
Jan. 15, 2019
Vietnam-produced seasonal influenza vaccine licensed for production and use
Milestone represents more than 10 years of partnership between Vietnamese manufacturers, PATH, the United States and Vietnam governments, and the World Health Organization.

Sabin Vaccine Institute  [to 19 Jan 2019]
No new digest content identified.
UNAIDS [to 19 Jan 2019]
Selected Press Releases/Reports/Statements
17 January 2019
Oral fluid HIV testing for gay men and other men who have sex with men in the Lao People’s Democratic Republic


UNICEF  [to 19 Jan 2019]
Selected Press Releases/Reports/Statements

UNICEF Executive Director Henrietta Fore’s remarks at Rotary International Assembly, San Diego, California,

“Lack of access to medical care in Syria is putting children’s lives at risk”
Statement attributable to Geert Cappelaere, UNICEF Regional Director for the Middle East and North Africa

Vaccine Confidence Project  [to 19 Jan 2019]
Confidence Commentary:
Japan: ‘Distressing’ Trend – Cervical Cancer Increasing
Heidi Larson | 14 Jan, 2019
Cervical cancer is on the rise among young women in Japan. This contrasts with the trend seen in most other developed countries, where rates have been falling, largely as a result of screening and vaccination against human papillomavirus (HPV) — the chief cause of virtually all cervical cancers worldwide.
The recent increase in cervical cancer in Japan can probably be explained by several factors, say researchers: low levels of cervical cancer screening, changes in sexual behavior leading to an increase in the prevalence of HPV infection, and the suspension in June 2013 of an active recommendation of HPV vaccination.

Vaccine Education Center – Children’s Hospital of Philadelphia  [to 19 Jan 2019]
No new digest content identified.


Wellcome Trust  [to 19 Jan 2019]
News | 17 January 2019
Researchers can now transfer Wellcome grants outside the UK
Alyson Fox, our Director of Grants, explains why we’re changing our policy on transferring grants to ensure research can thrive in the UK, EU and beyond.

News | 14 January 2019
2018 was a flagship year for Innovations – and 2019 is equally promising
Director of Innovation Stephen Caddick reflects on the past year and explains how his team has built its global portfolio to around £1 billion, touching the lives of more than 1.8 million people.
The Wistar Institute   [to 19 Jan 2019]
No new digest content identified.

World Organisation for Animal Health (OIE)   [to 19 Jan 2019]
No new digest content identified.




BIO    [to 19 Jan 2019]
Jan 17 2019
BIO Statement on China Approvals of Agricultural Biotechnology Products
Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement on the announcement that the People’s Republic of China’s National Biosafety Committee approved the final safety certificate for five agricultural biotechnology products.


DCVMN – Developing Country Vaccine Manufacturers Network  [to 19 Jan 2019]
No new digest content identified.


IFPMA   [to 19 Jan 2019]
No new digest content identified.

PhRMA    [to 19 Jan 2019]
January 17, 2019
PhRMA Welcomes Genentech and Gilead Sciences to Association